{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:32:03Z","timestamp":1794508323924,"version":"4.9.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GECILI20F0"],"award-info":[{"award-number":["GECILI20F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIOU14P0"],"award-info":[{"award-number":["LIOU14P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIOU14Y0"],"award-info":[{"award-number":["LIOU14Y0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["Naren19R0"],"award-info":[{"award-number":["Naren19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SZCZES18AB0"],"award-info":[{"award-number":["SZCZES18AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL141286"],"award-info":[{"award-number":["R01HL141286"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL125520"],"award-info":[{"award-number":["R01HL125520"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006415","name":"Ben B. and Iris M. Margolis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GECILI20F0"],"award-info":[{"award-number":["GECILI20F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIOU14P0"],"award-info":[{"award-number":["LIOU14P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["LIOU14Y0"],"award-info":[{"award-number":["LIOU14Y0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["Naren19R0"],"award-info":[{"award-number":["Naren19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SZCZES18AB0"],"award-info":[{"award-number":["SZCZES18AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL141286"],"award-info":[{"award-number":["R01HL141286"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL125520"],"award-info":[{"award-number":["R01HL125520"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Ben B. and Iris M. Margolis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Studies estimating the rate of lung function decline in cystic fibrosis have been inconsistent regarding the methods used. How the methodology used impacts the validity of the results and comparability between studies is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Cystic Fibrosis Foundation established a work group whose tasks were to examine the impact of differing approaches to estimating the rate of decline in lung function and to provide analysis guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a natural history cohort of 35,252 individuals with cystic fibrosis aged \u2a7e6 years in the Cystic Fibrosis Foundation Patient Registry (CFFPR), 2003\u20132016. Modeling strategies using linear and nonlinear forms of marginal and mixed-effects models, which have previously quantified the rate of forced expiratory volume in 1 second (FEV1) decline (percent predicted per year), were evaluated under clinically relevant scenarios of available lung function data. Scenarios varied by sample size (overall CFFPR, medium-sized cohort of 3,000 subjects, and small-sized cohort of 150), data collection\/reporting frequency (encounter, quarterly, and annual), inclusion of FEV1 during pulmonary exacerbation, and follow-up length (&amp;lt;2 yr, 2\u20135 yr, entire duration).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Rate of FEV1 decline estimates (percent predicted per year) differed between linear marginal and mixed-effects models; overall cohort estimates (95% confidence interval) were 1.26 (1.24\u20131.29) and 1.40 (1.38\u20131.42), respectively. Marginal models consistently estimated less rapid lung function decline than mixed-effects models across scenarios, except for short-term follow-up (both were \u223c1.4). Rate of decline estimates from nonlinear models diverged by age 30. Among mixed-effects models, nonlinear and stochastic terms fit best, except for short-term follow-up (&amp;lt;2 yr). Overall CFFPR analysis from a joint longitudinal-survival model implied that an increase in rate of decline of 1% predicted per year in FEV1 was associated with a 1.52-fold (52%) increase in the hazard of death\/lung transplant, but the results exhibited immortal cohort bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Differences were as high as 0.5% predicted per year between rate of decline estimates, but we found estimates were robust to lung function data availability scenarios, except short-term follow-up and older age ranges. Inconsistencies among previous study results may be attributable to inherent differences in study design, inclusion criteria, or covariate adjustment. Results-based decision points reported herein will support researchers in selecting a strategy to model lung function decline most reflective of nuanced, study-specific goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202209-829oc","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T11:21:24Z","timestamp":1678274484000},"page":"958-968","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":21,"title":["Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0705-715X","authenticated-orcid":false,"given":"Rhonda","family":"Szczesniak","sequence":"first","affiliation":[{"name":"Division of Biostatistics & Epidemiology and"},{"name":"Division of Pulmonary Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni-Rosalina","family":"Andrinopoulou","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and"},{"name":"Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiji","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Biostatistics & Epidemiology and"},{"name":"Department of Mathematical Sciences, University of Cincinnati, Cincinnati, Ohio"},{"name":"Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Afonso","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and"},{"name":"Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[{"name":"Cochin Hospital, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"Respiratory Medicine and Cystic Fibrosis National Reference Center, Cochin Hospital, Assistance Publique H\u00f4pitaux de Paris, Paris, France"},{"name":"European Reference Network for Rare Lung Diseases (ERN-LUNG), Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Cromwell","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Gecili","sequence":"additional","affiliation":[{"name":"Division of Biostatistics & Epidemiology and"},{"name":"Department of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Ghulam","sequence":"additional","affiliation":[{"name":"Division of Biostatistics & Epidemiology and"},{"name":"Basic Science Department, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Department of Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mayer-Hamblett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, and"},{"name":"Department of Biostatistics, University of Washington School of Medicine, Seattle, Washington"},{"name":"Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth H.","family":"Keogh","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0121-4847","authenticated-orcid":false,"given":"Theodore G.","family":"Liou","sequence":"additional","affiliation":[{"name":"Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Department of Internal Medicine, School of Medicine, and"},{"name":"Center for Quantitative Biology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Marshall","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Arizona, Tucson, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Ostrenga","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"David J.","family":"Pasta","sequence":"additional","affiliation":[{"name":"formerly ICON Clinical Research, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Wainwright","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Queensland Hospital and Health Service, Brisbane, Queensland, Australia"},{"name":"Child Health Research Centre, The University of Queensland, South Brisbane, Queensland, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Biostatistics & Epidemiology and"},{"name":"Department of Mathematical Sciences, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza K.","family":"Fink","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Foundation, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Schechter","sequence":"additional","affiliation":[{"name":"Childrens Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"2026012203274629600_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcf.2010.04.002","article-title":"Year-to-year changes in lung function in individuals with cystic fibrosis","volume":"9","author":"Liou","year":"2010","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib2","doi-asserted-by":"crossref","DOI":"10.1201\/9781420011579","volume-title":"Longitudinal data analysis","author":"Fitzmaurice","year":"2008"},{"key":"2026012203274629600_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/9781119513469","volume-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2011","edition":"2"},{"key":"2026012203274629600_bib4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ppul.23227","article-title":"Decline in lung function does not predict future decline in lung function in cystic fibrosis patients","volume":"50","author":"Rosenfeld","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2026012203274629600_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis","volume":"151","author":"Konstan","year":"2007","journal-title":"J Pediatr"},{"key":"2026012203274629600_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcf.2012.03.009","article-title":"Risk factors for rate of decline in FEV1 in adults with cystic fibrosis","volume":"11","author":"Konstan","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203274629600_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.201503-0578OC","article-title":"Sustained benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data","volume":"192","author":"Sawicki","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203274629600_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jcf.2021.03.008","article-title":"Real-world use of ivacaftor in Canada: a retrospective analysis using the Canadian Cystic Fibrosis Registry","volume":"20","author":"Kawala","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/thoraxjnl-2020-216265","article-title":"Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials","volume":"77","author":"Keogh","year":"2022","journal-title":"Thorax"},{"key":"2026012203274629600_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2026012203274629600_bib13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa066359","article-title":"Lung transplantation and survival in children with cystic fibrosis","volume":"357","author":"Liou","year":"2007","journal-title":"N Engl J Med"},{"key":"2026012203274629600_bib14","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1002\/sim.5469","article-title":"Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis","volume":"31","author":"Piccorelli","year":"2012","journal-title":"Stat Med"},{"key":"2026012203274629600_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1177\/0962280218764193","article-title":"Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry\u2014applications to cystic fibrosis","volume":"28","author":"Schluchter","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"2026012203274629600_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/rssb.12060","article-title":"Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference","volume":"77","author":"Barrett","year":"2015","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026012203274629600_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/EDE.0000000000000920","article-title":"Dynamic prediction of survival in cystic fibrosis: a landmarking analysis using UK patient registry data","volume":"30","author":"Keogh","year":"2019","journal-title":"Epidemiology"},{"key":"2026012203274629600_bib18","first-page":"55","article-title":"A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis","volume":"20","author":"Harun","year":"2016","journal-title":"Paediatr Respir Rev"},{"key":"2026012203274629600_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203274629600_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09031936.00187314","article-title":"Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis","volume":"46","author":"Stanojevic","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012203274629600_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200702-181OC","article-title":"Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis","volume":"176","author":"Konstan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203274629600_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ppul.23217","article-title":"Risk factors for lung function decline in a large cohort of young cystic fibrosis patients","volume":"50","author":"Cogen","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2026012203274629600_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of longitudinal data","author":"Diggle","year":"2002"},{"key":"2026012203274629600_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/sim.3478","article-title":"Fixed effects, random effects and GEE: what are the differences?","volume":"28","author":"Gardiner","year":"2009","journal-title":"Stat Med"},{"key":"2026012203274629600_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/EDE.0b013e3181caeb90","article-title":"To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health","volume":"21","author":"Hubbard","year":"2010","journal-title":"Epidemiology"},{"key":"2026012203274629600_bib26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3476(97)70025-8","article-title":"Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis","volume":"131","author":"Corey","year":"1997","journal-title":"J Pediatr"},{"key":"2026012203274629600_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"2026012203274629600_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"key":"2026012203274629600_bib29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/sim.1104","article-title":"Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients","volume":"21","author":"Schluchter","year":"2002","journal-title":"Stat Med"},{"key":"2026012203274629600_bib30","author":"Rizopoulos"},{"key":"2026012203274629600_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.annepidem.2013.08.009","article-title":"A semiparametric approach to estimate rapid lung function decline in cystic fibrosis","volume":"23","author":"Szczesniak","year":"2013","journal-title":"Ann Epidemiol"},{"key":"2026012203274629600_bib32","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"2026012203274629600_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinepi.2014.11.010","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"68","author":"Collins","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"2026012203274629600_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcf.2016.05.014","article-title":"Physiologic endpoints for clinical studies for cystic fibrosis","volume":"15","author":"Stanojevic","year":"2016","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.spl.2018.02.015","article-title":"Big data: some statistical issues","volume":"136","author":"Cox","year":"2018","journal-title":"Stat Probab Lett"},{"key":"2026012203274629600_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ppul.1950150204","article-title":"Pulmonary function between 6 and 18 years of age","volume":"15","author":"Wang","year":"1993","journal-title":"Pediatr Pulmonol"},{"key":"2026012203274629600_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203274629600_bib38","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41598-020-63590-8","article-title":"Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods","volume":"10","author":"Liou","year":"2020","journal-title":"Sci Rep"},{"key":"2026012203274629600_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcf.2017.11.019","article-title":"Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: a longitudinal study using UK patient registry data","volume":"17","author":"Keogh","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib40","doi-asserted-by":"crossref","first-page":"1753466618820186","DOI":"10.1177\/1753466618820186","article-title":"Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor\/ivacaftor","volume":"13","author":"Rubin","year":"2019","journal-title":"Ther Adv Respir Dis"},{"key":"2026012203274629600_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thoraxjnl-2021-216849","article-title":"Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data","volume":"77","author":"Schl\u00fcter","year":"2022","journal-title":"Thorax"},{"key":"2026012203274629600_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(22)01043-8","article-title":"Factors associated with receiving CF care and use of telehealth in 2020 among persons with cystic fibrosis in the United States","author":"Collaco","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib43","volume-title":"Time series: theory and methods","author":"Brockwell","year":"1998"},{"key":"2026012203274629600_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcf.2018.02.003","article-title":"Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis","volume":"17","author":"Wagener","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2019.06.008","article-title":"Predictors of pulmonary exacerbation treatment in cystic fibrosis","volume":"19","author":"Sanders","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2026012203274629600_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1513\/AnnalsATS.201702-111OC","article-title":"Treatment setting and outcomes of cystic fibrosis pulmonary exacerbations","volume":"15","author":"Schechter","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203274629600_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0962280217723675","article-title":"Interpretation of mixed models and marginal models with cohort attrition due to death and drop-out","volume":"28","author":"Rouanet","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"2026012203274629600_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12874-022-01581-1","article-title":"Immortal time bias for life-long conditions in retrospective observational studies using electronic health records","volume":"22","author":"Tyrer","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"2026012203274629600_bib49","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1002\/sim.7932","article-title":"Analysis of longitudinal data from outcome-dependent visit processes: failure of proposed methods in realistic settings and potential improvements","volume":"37","author":"Neuhaus","year":"2018","journal-title":"Stat Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/7\/958\/66269133\/annalsats_20_7_958.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/7\/958\/66269133\/annalsats_20_7_958.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:29:04Z","timestamp":1769070544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/20\/7\/958\/8414688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202209-829oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"2022-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}